ConductScience.org, home

Paper2876451

Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group.

Psychopharmacology (Berl), 1986. Cited by 197 papers, by iCite.

Cite this record

ConductScience Library. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group. Papers, record 2876451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2876451

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group.
PubMed
Journal
Psychopharmacology (Berl)
PubMed
Year
1986
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
197
iCite
Relative citation ratio, by iCite
9.34
iCite
Revised in PubMed
2026-10-10
PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antidepressive AgentsMajor topic
ClomipramineMajor topic
Depressive DisorderMajor topic
PropylaminesMajor topic
Adolescent
Adult
Citalopram
Clinical Trials as Topic
Female
Humans
Male
Psychiatric Status Rating Scales
Random Allocation

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113812965
Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression. The role of the electrical stimulation and of the seizure studied by variation of stimulus intensity and modification by lidocaine of seizure discharge.
Acta Psychiatr Scand Suppl1960https://conductscience.org/library/papers/13812965PubMed
23899675Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3899675PubMed
34148426Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms.J Pharm Pharmacol1973https://conductscience.org/library/papers/4148426PubMed
46080235Development of a rating scale for primary depressive illness.Br J Soc Clin Psychol1967https://conductscience.org/library/papers/6080235PubMed
56935914Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171).Acta Psychiatr Scand1980https://conductscience.org/library/papers/6935914PubMed
6444789Clinical response and tricyclic plasma levels during treatment with clomipramine.Br J Psychiatry1979https://conductscience.org/library/papers/444789PubMed
7978187On the methods and theory of reliability.J Nerv Ment Dis1976https://conductscience.org/library/papers/978187PubMed
81136841Quantitative rating of depressive states.Acta Psychiatr Scand1975https://conductscience.org/library/papers/1136841PubMed
97015793The Hamilton depression scale. Evaluation of objectivity using logistic models.Acta Psychiatr Scand1981https://conductscience.org/library/papers/7015793PubMed
106825388Imipramine metabolites in blood of patients during therapy and after overdose.Clin Pharmacol Ther1983https://conductscience.org/library/papers/6825388PubMed
113929308Orthostatic side effects of clomipramine and citalopram during treatment for depression.Psychopharmacology (Berl)1985https://conductscience.org/library/papers/3929308PubMed
126438690Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants.Psychopharmacology (Berl)1984https://conductscience.org/library/papers/6438690PubMed
136116242Current concepts of the mechanisms of action of antidepressant drugs.Pharmacol Ther1981https://conductscience.org/library/papers/6116242PubMed
147468286The WHO Depression Scale. Relationship to the Newcastle Scales.Acta Psychiatr Scand1980https://conductscience.org/library/papers/7468286PubMed
15498703Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression.Clin Pharmacol Ther1979https://conductscience.org/library/papers/498703PubMed
166794083Cardiovascular effect of imipramine and nortriptyline in elderly patients.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6794083PubMed
176812140Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study.Psychopharmacology (Berl)1982https://conductscience.org/library/papers/6812140PubMed
18548213Clomipramine: plasma levels and clinical effects.Commun Psychopharmacol1979https://conductscience.org/library/papers/548213PubMed
197094971Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7094971PubMed
205470429Correlation of subjective side effects with plasma concentrations of nortriptyline.Br Med J1970https://conductscience.org/library/papers/5470429PubMed

See all 24 referencesDownload CSV of references

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 197 citations.

PMIDTitleJournalYearIn PapersSource
37701889The past, present and future of anticholinergic drugs.Ther Adv Psychopharmacol2023https://conductscience.org/library/papers/37701889PubMed
34959688A New Paradigm to Indicate Antidepressant Treatments.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34959688PubMed
33014119Efficacy of nicotine administration on obsessions and compulsions in OCD: a systematic review.Ann Gen Psychiatry2020https://conductscience.org/library/papers/33014119PubMed
26619226Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?Future Med Chem2015https://conductscience.org/library/papers/26619226PubMed
23336036Future directions for serotonin and antidepressants.ACS Chem Neurosci2013https://conductscience.org/library/papers/23336036PubMed
22786497Citalopram versus other anti-depressive agents for depression.Cochrane Database Syst Rev2012https://conductscience.org/library/papers/22786497PubMed
22672296Antidepressant effects on emotional temperament: toward a biobehavioral research paradigm for major depressive disorder.CNS Neurosci Ther2012https://conductscience.org/library/papers/22672296PubMed
22021869Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials.BMJ Open2011https://conductscience.org/library/papers/22021869PubMed
21044654Psychomotor retardation in depression: biological underpinnings, measurement, and treatment.Prog Neuropsychopharmacol Biol Psychiatry2011https://conductscience.org/library/papers/21044654PubMed
19300553Duloxetine in the treatment of major depressive disorder.Neuropsychiatr Dis Treat2007https://conductscience.org/library/papers/19300553PubMed
18568124What moderator characteristics are associated with better prognosis for depression?Neuropsychiatr Dis Treat2005https://conductscience.org/library/papers/18568124PubMed
17955213Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis.Psychopharmacology (Berl)2008https://conductscience.org/library/papers/17955213PubMed
17934554Translating evidence on depression and physical symptoms into effective clinical practice.Prim Care Companion J Clin Psychiatry2007https://conductscience.org/library/papers/17934554PubMed
17472422An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.Drug Saf2007https://conductscience.org/library/papers/17472422PubMed
16889105Treatments in depression.Dialogues Clin Neurosci2006https://conductscience.org/library/papers/16889105PubMed
16001091Single-action versus dual-action antidepressants.Prim Care Companion J Clin Psychiatry2004https://conductscience.org/library/papers/16001091PubMed
15960553Remission from depression : a review of venlafaxine clinical and economic evidence.Pharmacoeconomics2005https://conductscience.org/library/papers/15960553PubMed
15697327Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.CNS Drugs2005https://conductscience.org/library/papers/15697327PubMed
15631624Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.BMC Psychiatry2005https://conductscience.org/library/papers/15631624PubMed
15309042The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.J Psychiatry Neurosci2004https://conductscience.org/library/papers/15309042PubMed

See all 39 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Authors
  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2876451

GET https://conductscience.org/api/papers/v1/2876451/references?page=2